Market research
ERGO.LSE Ergomed plc
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 701M
- P/E ratio
- 46.41
- Analyst target
- 1434.29
- Dividend yield
- 0.0%
- Beta
- 0.79
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- GB00BN7ZCY67
- Market cap
- 701M
- P/E ratio
- 46.41
- Analyst target
- 1434.29
- Dividend yield
- 0.0%
- Beta
- 0.79
About
About Ergomed plc
Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ERGO.LSE discussion.
5 years, 5 months ago
Ergomed plc is currently in a long term uptrend where the price is trading 6.7% above its 200 day moving average.
From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.8.
Ergomed plc's total revenue sank by 0.0% to $17M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $980K since the same quarter in the previous year.
Finally, its free cash flow grew by 18.1% to $5M since the same quarter in the previous year.
Based on the above factors, Ergomed plc gets an overall score of 3/5.